PIVLAZ

Swiss trademark · 745742 · Combined mark · In force

Register entry

Registration number
745742
Application number
05190/2020
Status
In force
Type
Combined mark
As registered
PIVLAZ ((fig.))
Filed
Apr 16, 2020
Registered
Apr 17, 2020
Published
Apr 17, 2020
Protected until
Apr 16, 2030
Language of procedure
German
Vienna classes
26.11.03, 26.11.09, 26.11.13
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Behandlung von Hirnblutungen und deren Folgen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 7, 2026

    Pledge entered

    Pledgee
    BioPharma Credit PLC, 19th Floor 51 Lime Street, London, United Kingdom, EC3M 7DQ, United Kingdom

    Published in Swissreg on 07.07.2026

  2. Oct 6, 2020

    Agent’s address changed

    Representative
    Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich → Keller Schneider Patent- und Markenanwälte AG (Zürich), Beethovenstrasse 49, Postfach, 8027 Zürich

    Published in Swissreg on 06.10.2020

  3. Apr 17, 2020

    Registered

    Published in Swissreg on 17.04.2020

Parties

Holder

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91, 4123 Allschwil

Agent

Keller Schneider Patent- und Markenanwälte AG (Zürich)

Beethovenstrasse 49 Postfach, 8027 Zürich

Struck from the register

Pledgee

BioPharma Credit PLC

19th Floor 51 Lime Street, London, United Kingdom, EC3M 7DQ, GB

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.